All articles tagged with #drug review process
Richard Pazdur, the top drug regulator at the FDA, resigned just three weeks after taking the role amid disagreements over agency overhaul plans and concerns about transparency and legality, highlighting ongoing turmoil within the agency.
The FDA announced a new Commissioner’s National Priority Voucher program to expedite drug reviews for companies aligned with U.S. health priorities, reducing review times from 10-12 months to 1-2 months through a team-based, multidisciplinary review process, aiming to bring more cures and treatments to Americans efficiently while maintaining safety standards.